Drug
Bmn 333
Bmn 333: highest development phase Phase 2/3, developed by BioMarin Pharmaceutical. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2/3
- Developer
- BioMarin Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| BMN 333 NCT07441876 | Phase 2/3 | Achondroplasia |
Latest
No recent events.
Follow Bmn 333 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.